ADAGE CAPITAL PARTNERS GP, L.L.C. - Q3 2014 holdings

$40.5 Billion is the total value of ADAGE CAPITAL PARTNERS GP, L.L.C.'s 708 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 0.0% .

 Value Shares↓ Weighting
PBYI  PUMA BIOTECHNOLOGY INC$1,356,668,000
+261.5%
5,686,6680.0%3.35%
+245.6%
AMAG  AMAG PHARMACEUTICALS INC$121,150,000
+54.0%
3,796,5920.0%0.30%
+47.3%
GLD  SPDR GOLD TRUST$81,347,000
-9.2%
700,0000.0%0.20%
-13.4%
BDBD  BOULDER BRANDS INC$78,474,000
-3.9%
5,757,4290.0%0.19%
-8.1%
 UNITED RENTALS INCnote 4.000%11/1$74,808,000
+6.1%
7,500,0000.0%0.18%
+1.6%
HUBA  HUBBELL INCcl a$72,575,000
-0.5%
584,5320.0%0.18%
-4.8%
EE  EL PASO ELEC CO$51,178,000
-9.1%
1,400,2090.0%0.13%
-13.1%
Q  QUINTILES TRANSNATIO HLDGS I$36,257,000
+4.7%
650,0000.0%0.09%0.0%
 EQUINIX INCnote 4.750% 6/1$34,320,000
+0.9%
13,328,0000.0%0.08%
-3.4%
PEGI  PATTERN ENERGY GROUP INCcl a$29,510,000
-6.6%
954,4120.0%0.07%
-11.0%
SGMO  SANGAMO BIOSCIENCES INC$27,502,000
-29.4%
2,550,0000.0%0.07%
-32.7%
FWLT  FOSTER WHEELER AG$26,877,000
-7.2%
850,0000.0%0.07%
-12.0%
 MYLAN INCnote 3.750% 9/1$25,622,000
-11.9%
7,500,0000.0%0.06%
-16.0%
OVAS  OVASCIENCE INC$24,900,000
+81.0%
1,500,0000.0%0.06%
+72.2%
ALRPRB  ALERE INCperp pfd conv se$24,243,000
+2.0%
74,7430.0%0.06%
-1.6%
KYTH  KYTHERA BIOPHARMACEUTICALS I$22,932,000
-14.6%
700,0000.0%0.06%
-17.4%
BG  BUNGE LIMITED$21,956,000
+11.4%
260,6710.0%0.05%
+5.9%
 NOVELLUS SYS INCnote 2.625% 5/1$21,794,000
+7.7%
10,000,0000.0%0.05%
+3.8%
SU  SUNCOR ENERGY INC NEW$18,076,000
-15.2%
500,0000.0%0.04%
-18.2%
PSUNQ  PACIFIC SUNWEAR CALIF INC$17,910,000
-24.4%
9,950,0530.0%0.04%
-27.9%
MWA  MUELLER WTR PRODS INC$16,150,000
-4.2%
1,950,4280.0%0.04%
-9.1%
VAL  VALSPAR CORP$15,798,000
+3.7%
200,0000.0%0.04%0.0%
GNMK  GENMARK DIAGNOSTICS INC$14,802,000
-33.7%
1,650,2270.0%0.04%
-36.2%
LMIA  LMI AEROSPACE INC$14,485,000
-2.1%
1,131,6490.0%0.04%
-5.3%
SFXEQ  SFX ENTMT INC$13,303,000
-38.0%
2,650,0000.0%0.03%
-40.0%
ARAY  ACCURAY INC$13,515,000
-17.5%
1,861,5690.0%0.03%
-21.4%
ODP  OFFICE DEPOT INC$12,860,000
-9.7%
2,501,8770.0%0.03%
-13.5%
SAPE  SAPIENT CORP$12,950,000
-13.8%
925,0000.0%0.03%
-17.9%
 CEMEX SAB DE CVnote 3.250% 3/1$11,275,000
-2.9%
8,000,0000.0%0.03%
-6.7%
MNDL  MANDALAY DIGITAL GROUP INC$11,056,000
+16.0%
2,413,8910.0%0.03%
+8.0%
ATR  APTARGROUP INC$10,277,000
-9.4%
169,3130.0%0.02%
-13.8%
PACW  PACWEST BANCORP DEL$9,483,000
-4.5%
230,0000.0%0.02%
-11.5%
 MICROCHIP TECHNOLOGY INCsdcv 2.125%12/1$9,278,000
-2.9%
5,000,0000.0%0.02%
-8.0%
AGRX  AGILE THERAPEUTICS INC$8,760,000
-16.3%
1,200,0000.0%0.02%
-18.5%
CSLT  CASTLIGHT HEALTH INCcl b$8,786,000
-14.9%
678,9820.0%0.02%
-18.5%
WEX  WEX INC$8,826,000
+5.1%
80,0000.0%0.02%0.0%
INFI  INFINITY PHARMACEUTICALS INC$8,052,000
+5.3%
600,0000.0%0.02%0.0%
KND  KINDRED HEALTHCARE INC$7,760,000
-16.0%
400,0000.0%0.02%
-20.8%
BIOS  BIOSCRIP INC$6,910,000
-17.1%
1,000,0000.0%0.02%
-22.7%
TRVN  TREVENA INC$5,136,000
+13.6%
800,0000.0%0.01%
+8.3%
KAR  KAR AUCTION SVCS INC$4,452,000
-10.2%
155,5000.0%0.01%
-15.4%
DSX  DIANA SHIPPING INC$3,576,000
-17.9%
400,0000.0%0.01%
-18.2%
CNAT  CONATUS PHARMACEUTICALS INC$3,366,000
-32.8%
550,0000.0%0.01%
-38.5%
ELGX  ENDOLOGIX INC$3,104,000
-30.3%
292,8370.0%0.01%
-33.3%
RJF  RAYMOND JAMES FINANCIAL INC$2,679,000
+5.6%
50,0000.0%0.01%0.0%
CYN  CITY NATL CORP$2,951,000
-0.1%
39,0000.0%0.01%
-12.5%
ICEL  CELLULAR DYNAMICS INTL INC$2,404,000
-51.8%
342,0000.0%0.01%
-53.8%
SB  SAFE BULKERS INC$1,932,000
-31.8%
290,2040.0%0.01%
-28.6%
ONTY  ONCOTHYREON INC$1,824,000
-40.7%
950,0000.0%0.01%
-37.5%
BXC  BLUELINX HLDGS INC$1,786,000
-6.4%
1,363,0040.0%0.00%
-20.0%
TWOU  2U INC$1,559,000
-7.3%
100,0000.0%0.00%0.0%
RIGL  RIGEL PHARMACEUTICALS INC$1,164,000
-46.6%
600,0000.0%0.00%
-50.0%
QTM  QUANTUM CORP$906,000
-4.9%
781,3000.0%0.00%0.0%
CUB  CUBIC CORP$657,000
+5.1%
14,0360.0%0.00%0.0%
MEG  MEDIA GEN INC$656,000
-36.1%
50,0000.0%0.00%
-33.3%
GCVRZ  SANOFIright 12/31/2020$286,000
-6.8%
614,4550.0%0.00%0.0%
CYTX  CYTORI THERAPEUTICS INC$84,000
-71.9%
124,9110.0%0.00%
-100.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2014-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
APPLE INC43Q3 20236.0%
MICROSOFT CORP43Q3 20235.5%
AMAZON COM INC43Q3 20234.0%
BERKSHIRE HATHAWAY INC DEL43Q3 20231.3%
JPMORGAN CHASE & CO43Q3 20231.3%
EXXON MOBIL CORP43Q3 20231.6%
JOHNSON & JOHNSON43Q3 20231.2%
PROCTER & GAMBLE CO43Q3 20231.0%
WELLS FARGO CO NEW43Q3 20231.6%
UNITEDHEALTH GROUP INC43Q3 20231.2%

View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete holdings history.

Latest significant ownerships (13-D/G)
ADAGE CAPITAL PARTNERS GP, L.L.C. Q3 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CymaBay Therapeutics, Inc.September 11, 20233,685,6253.8%
Verastem, Inc.August 31, 20231,300,0005.2%
Molecular Templates, Inc.July 18, 20234,391,4895.4%
ABEONA THERAPEUTICS INC.July 06, 20233,249,99415.3%
Praxis Precision Medicines, Inc.June 30, 20237,930,6386.2%
REATA PHARMACEUTICALS INCJune 26, 20231,730,8415.2%
Provention Bio, Inc.February 21, 20235,398,8256.0%
ADAMS NATURAL RESOURCES FUND, INC.February 09, 20231,308,7915.4%
Akili, Inc.Sold outFebruary 09, 202300.0%
Ambrx Biopharma Inc.February 09, 20237,191,0372.7%

View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-05-15
SC 13G/A2024-04-11
SC 13G2024-02-26
SC 13G2024-02-26
SC 13G2024-02-23
13F-HR2024-02-14
SC 13G2024-02-12
SC 13G/A2024-02-07
SC 13G/A2024-02-07
SC 13G/A2024-02-07

View ADAGE CAPITAL PARTNERS GP, L.L.C.'s complete filings history.

Compare quarters

Export ADAGE CAPITAL PARTNERS GP, L.L.C.'s holdings